-IndiaSpend.com/ Scroll.in PepsiCo has appealed in the Delhi High Court against the revocation of its registration of a potato variety. An ongoing court case between multinational food and beverage company PepsiCo India and the petitioner, farmers’ rights activist Kavitha Kuruganti, has highlighted the tensions between plant-breeding corporations which want a stricter Intellectual Property Rights regime and farmers’ rights in developing countries. International Intellectual Property Rights conventions seek to give plant variety breeders the...

-The Telegraph There is no mention of compliance with ‘good manufacturing practices’ or the need to make inspection reports public, leaving the process of regulation vague and dependent on whims of drug inspectors This month, the Union ministry of health published the draft new drugs, medical devices and cosmetics bill to replace the antiquated Drugs and Cosmetics Act, 1940. Yet, most of the draft bill appears to be a copy of the...

-The Hindu They write to Prime Minister asking him to renegotiate the draft proposal to waive Intellectual Property Rights on vaccines and highlight the need for active engagement to improve it A group of non governmental organisations has written to Prime Minister Narendra Modi, to prod the Union Commerce Ministry into “proactively engaging” with a draft proposal at the World Trade Organisation-TRIPS in Geneva to waive Intellectual Property Rights, mostly controlled by...

-The Hindu “The current version of the text added new burdensome conditions that would impose additional limits on countries using non-voluntary licensing” Six experts from India, South Africa and the United States have written to Prime Minister Narendra Modi to reject the current version of a proposal at the World Trade Organisation on intellectual property waivers for COVID-19 medicines, that includes vaccines, drugs and diagnostics. In October 2020, at the WTO’s Trade Related...

-Down to Earth Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers to production of COVID-19 medical tools We are back to square one. Back to the beginning after 18 months of a wearying, tortuous series of negotiations that carried on while millions of lives hung in the balance — and still do. The waiver of intellectual property (IP) rights on medicines, vaccines and diagnostics to fight the...